# Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-rifampicin-for-multiple-system-atrophy-a-randomised/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Phillip A. Low,David L. Robertson,Sid Gilman,Horacio Kaufmann,Wolfgang Singer,Italo Biaggioni,Roy Freeman,Susan Perlman,Robert A. Hauser,William P. Cheshire,Stephanie Lessig,Steven Vernino,Jay Mandrekar,William D. Dupont,Thomas Chelimsky,Wendy R. Galpern |
| Citations | 113 |
| DOI | 10.1016/s1474-4422(13)70301-6 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/4030757 |
| OpenAlex ID | https://openalex.org/W2141041456 |
| PMID | 24507091 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Stephanie Lessig](https://scholariq.org/researchers/stephanie-lessig/)

## Paper primary topic

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)

## Paper topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Parkinson's Disease and Spinal Disorders](https://scholariq.org/topics/parkinson-s-disease-and-spinal-disorders/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.